Estimation of minimum clinically important difference for pain in fibromyalgia

The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders

(2009) John T. Farrar et al.   JOURNAL OF PAIN

The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgia. A Randomized, Double-blind, Placebo-controlled Trial

(2009) P. J. MEASE et al.   JOURNAL OF RHEUMATOLOGY

Psychometric Properties of the Neck Disability Index and Numeric Pain Rating Scale in Patients With Mechanical Neck Pain

(2008) Joshua A. Cleland et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

(2008) Daniel J. Clauw et al.   CLINICAL THERAPEUTICS

A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia

(2008) Lesley M. Arnold et al.   JOURNAL OF PAIN

Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: Effects on painful physical symptoms of depression

(2008) David G.S. Perahia et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial☆

(2008) Jon I. Russell et al.   PAIN

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin

(2008) Leslie J. Crofford et al.   PAIN

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN